CD38 targeting in multiple myeloma

被引：0
|
作者：
Abel, Andrea [1 ]
Cano, Laia Querol [1 ]
van Spriel, Annemiek [1 ]
Hammink, Roel [1 ]
ter Beest, Martin [1 ]
机构：
[1] Radboud Inst Mol Life Sci RIMLS, Nijmegen, Netherlands
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-377
引用
收藏
页码：S248 / S248
页数：1
相关论文
共 50 条
  • [41] A Fully Human IgE Specific for CD38 as a Potential Therapy for Multiple Myeloma
    Candelaria, Pierre V.
    Nava, Miguel
    Daniels-Wells, Tracy R.
    Penichet, Manuel L.
    CANCERS, 2023, 15 (18)
  • [42] Multiple Myeloma New Perspectives by Engaging CD38: Darzalex® convinced as Monotherapy
    不详
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 (7-8) : 482 - 482
  • [43] CD38: targeted therapy in multiple myeloma and therapeutic potential for solid cancers
    Jiao, Ying
    Yi, Ming
    Xu, Linping
    Chu, Qian
    Yan, Yongxiang
    Luo, Suxia
    Wu, Kongming
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2020, 29 (11) : 1295 - 1308
  • [44] CD38 Enzymatic Activity Modulates Drug Susceptibility in Multiple Myeloma Cells
    Kawano, Yawara
    Bai, Junzhe
    Kushima, Saki
    Hata, Hiroyuki
    Yasunaga, Jun-ichirou
    BLOOD, 2024, 144 : 6833 - 6833
  • [45] Inecalcitol Induces CD38 Expression in Multiple Myeloma and Myeloid Cell Lines
    Benjamin, Susan
    Planquette, Cecile
    Delansorne, Remi
    BLOOD, 2016, 128 (22)
  • [46] Immunomodulatory properties of CD38 antibodies and their effect on anticancer efficacy in multiple myeloma
    Bisht, Kamlesh
    Fukao, Taro
    Chiron, Marielle
    Richardson, Paul
    Atanackovic, Djordje
    Chini, Eduardo
    Chng, Wee Joo
    Van De Velde, Helgi
    Malavasi, Fabio
    CANCER MEDICINE, 2023, 12 (20): : 20332 - 20352
  • [47] CD38 and CD45 expression on plasma cells and response to daratumumab in Multiple Myeloma
    Lammers, Eline
    Cuenca, Marta
    Bloem, Andries
    Minnema, Monique
    Jak, Margot
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E164 - E164
  • [48] Flow cytometry analysis of CD38 And CD45 expression intensity in multiple myeloma
    Zanned, S.
    Chaabouni, S.
    Kasdallah, M.
    Barbat, M.
    Cherni, H.
    Safra, I.
    CLINICA CHIMICA ACTA, 2024, 558
  • [49] EFFECT OF IMID COMPOUNDS ON CD38 EXPRESSION ON MULTIPLE MYELOMA CELLS: MOR202, A HUMAN CD38 ANTIBODY IN COMBINATION WITH POMALIDOMIDE
    Boxhammer, R.
    Steidl, S.
    Endell, J.
    HAEMATOLOGICA, 2015, 100 : 247 - 247
  • [50] Controversy in the Use of CD38 Antibody for Treatment of Myeloma: Is High CD38 Expression Good or Bad?
    Plesner, Torben
    van de Donk, Niels W. C. J.
    Richardson, Paul G.
    CELLS, 2020, 9 (02)
12345